Apply for Funding

Product Development Platform

Past RFP

RFP Product Development Platform 2019-002

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

Scope for the RFP-PD-2019-002 is primarily focused on continuation projects, diagnostics projects, and late stage projects (e.g. FIH and POC). 

 

Interested applicants can find detailed information on the RFP and the Intent to Apply form below.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

July 10, 2019

Intent to Apply

No later than 10:00 am Tokyo time on August 27, 2019 

*Applicants are encouraged to submit the ITA well in advance of the Full Proposal submission deadline shown below to secure sufficient time to prepare full proposal.

Submit via Editorial Manager® for Product Development Platform (http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on September 6, 2019

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2019-002_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on September 10, 2019

Submit via Editorial Manager® for Product Development Platform (http://www.editorialmanager.com/ghitfund/)

Proposals Evaluation and Interview Processes

September - February 2020

Award Notification to All Applicants

February 2020

Investment Agreement Fully Executed (Awarded Proposals)

March 2020

RFP Product Development Platform 2019-001

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

Interested applicants can find detailed information on the RFP and the Intent to Apply form below.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

December 3, 2018

Intent to Apply

No later than 5:00 pm Tokyo time on January 11, 2019

Submit via Editorial Manager® for Product Development

Platform (http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on January 29, 2019

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2019-001_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on February 4, 2019

Submit via Editorial Manager® for Product Development

Platform (http://www.editorialmanager.com/ghitfund/)

Proposals Evaluation and Interview Processes

February 2019 - July 2019

Award Notification to All Applicants

July 2019

Investment Agreement Fully Executed (Awarded Proposals)

August 2019

GHIT Fund RFP Product Development Platform 2018-002

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

Interested applicants can find detailed information on the RFP and the Intent to Apply form below.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

July 20, 2018

Intent to Apply

No later than 10:00 am Tokyo time on August 10, 2018

Submit via Editorial Manager® for Product Development Platform

(http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on September 3, 2018

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2018-002_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on September 7, 2018

Submit via Editorial Manager® for Product Development Platform

(http://www.editorialmanager.com/ghitfund/)

Proposals Evaluation and Interview Processes

September 2018 - February 2019

Award Notification to All Applicants

February 2019

Investment Agreement Fully Executed (Awarded Proposals)

March 2019

GHIT Fund RFP Product Development Platform 2018-001

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

Interested applicants can find detailed information on the RFP and the Intent to Apply form below.

 


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

January 12, 2018

Intent to Apply

No later than 10:00 am Tokyo time on February 1, 2018

Submit via Editorial Manager® for Product Development Platform (http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on February 19, 2018

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2018-001_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on February 26, 2018

Submit via Editorial Manager® for Product Development

Platform (http://www.editorialmanager.com/ghitfund/)

Proposals Evaluation and Interview Processes

February 2018 - July 2018

Award Notification to All Applicants

July 2018

Investment Agreement Fully Executed (Awarded Proposals)

August 2018

GHIT Fund RFP Product Development Platform 2017-002

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

Interested applicants can find detailed information on the RFP and the Intent to Apply form below.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

July 25, 2017

Intent to Apply

No later than 10:00 am Tokyo time on August 21, 2017

Submit via Editorial Manager® for Product Development Platform

(http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on August 17, 2017

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2017-002_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on September 19, 2017

Submit via Editorial Manager® for Product Development Platform

(http://www.editorialmanager.com/ghitfund/)

Proposals Evaluation and Interview Processes

September 2017 - February 2018

Award Notification to All Applicants

February 2018

Investment Agreement Fully Executed (Awarded Proposals)

March 2018

GHIT Fund RFP Product Development Platform 2017-001

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

Interested applicants can find detailed information on the RFP and the Intent to Apply form below.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

October 7, 2016

Intent to Apply

No later than 10:00 am Tokyo time on November 10, 2016

Submit via Editorial Manager® for Product Development Platform

(http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on December 26, 2016

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2017-001_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on January 13, 2017

Submit via Editorial Manager® for Product Development Platform

(http://www.editorialmanager.com/ghitfund/)

Proposals Evaluation and Interview Processes

January 2017 - July 2017

Award Notification to All Applicants

End of July 2017

Investment Agreement Fully Executed (Awarded Proposals)

Mid-September 2017

GHIT Fund RFP Product Development Platform 2016-002

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

Interested applicants can find detailed information on the RFP and the Intent to Apply form below.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

July 1, 2016

Intent to Apply

No later than 10:00 am Tokyo time on July 28, 2016

Submit via Editorial Manager® for Product Development

Platform (http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on August 23, 2016

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2016-002_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on September 1, 2016

Submit via Editorial Manager® for Product Development

Platform (http://www.editorialmanager.com/ghitfund/)

Award Notification to All Applicants

No later than February 10, 2017

GHIT Fund RFP Product Development Platform 2016-001

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

If you are interested in applying for the platform, please see RFP.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

October 1, 2015

Intent to Apply

No later than 10:00 am Tokyo time on November 16, 2015 Submit via Editorial Manager® for Product Development Platform (http://www.editorialmanager.com/ghitfund/)

Q&A

No later than 10:00 am Tokyo time on December 18, 2015 Submit questions to RFPResponse@ghitfund.org 
Email Subject Line: GHIT-RFP-PD-2016-001_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on January 6, 2016 Submit via Editorial Manager® for Product Development Platform (http://www.editorialmanager.com/ghitfund/)

Award Notification to All Applicants

No later than August 1, 2016

GHIT Fund RFP Product Development Platform 2015-002

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

If you are interested in applying for the platform, please see RFP.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

June 22, 2015

Intent to Apply

No later than 10:00 am Tokyo time on August 5, 2015

Submit via Editorial Manager® for Product Development Platform

 

Q&A

No later than 10:00 am Tokyo time on September 1, 2015

Submit questions to RFPResponse@ghitfund.org

Email Subject Line: GHIT-RFP-PD-2015-002_Questions

Full Proposal Due

No later than 10:00 am Tokyo time on September 9, 2015

Submit via Editorial Manager® for Product Development Platform 

Award Notification to All Applicants

No later than February 12, 2016

GHIT Fund RFP Product Development Platform 2015-001

The GHIT Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

 

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Activities to support licensure and WHO prequalification

 

If you are interested in applying for the platform, please see RFP.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

February 6, 2015

Intent to Apply
No later than 10:00 am Tokyo time on March 13, 2015
 
Q&A
No later than 10:00 am Tokyo time on March 30, 2015
Submit questions to RFPResponse@ghitfund.org
Email Subject Line: GHIT-RFP-PD-2015-001_Questions
Full Proposal Due
No later than 10:00 am Tokyo time on April 3, 2015
Award Notification to All Applicants

No later than August 1, 2015

GHIT Fund RFP Product Development Platform 2014-002

The GHIT Fund announces a funding award opportunity for the development of new medicines, vaccines, or diagnostics for neglected tropical diseases (NTDs) that are prevalent in the developing world. Proposed projects should address NTD-related health needs in the developing world or fill a gap in global health technologies focused on NTDs. 

 

In April 2014, the GHIT Fund endorsed the 2012 London Declaration on Neglected Tropical Diseases and joined its signatories, representing NGOs, pharmaceutical companies, government agencies, and academic-research sectors, in commitment to the eradication, elimination, and control of NTDs in the world’s poorest populations. In line with this commitment, This RFP will focus specifically on “Combatting Neglected Tropical Diseases (NTDs)."

(For your referernce; www.ghitfund.org/about/mediacenter/pressdetail/detail/81)

 

The proposed collaboration project may include R&D activities from pre-clinical research (post-lead optimization) through licensure. More specifically, we seek to fund a portfolio of innovative collaboration projects, such as:

      ■ Pre-clinical development (e.g., lead-optimization, in-vivo studies, formulation development, chemistry and process validation)

      ■ Clinical development (e.g., Phase 1, Phase 2, Phase 3, manufacturing scale up)

      ■ Activities to support licensure and WHO pre qualification 

 

If you are interested in applying for the grant, please download RFP related documents.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

13th June, 2014

Intent to Apply

From 10:00am Tokyo Time on 16th June, 2014

To 10:00 am Tokyo Time on 18th August, 2014

Submit GHIT RFP 2014-002 Intent To Apply using our online submission system (http://www.editorialmanager.com/ghitfund/)

Q&A

Submit Questions to RFPResponse@ghitfund.org no later than 11th September, 2014.

Email Subject Line: GHIT Fund-RFP-2014-002 Questions

Full Proposal Due

No later than 10:00 am Tokyo Time on 18th September, 2014

Award Notification to All Applicants

No later than 16th February, 2015

GHIT Fund RFP Product Development Platform 2014-001

The GHIT Fund announces a funding award opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration project may include R&D activities from pre-clinical research (post-lead optimization) through licensure. More specifically, we seek to fund a portfolio of innovative collaboration projects, such as:

  • ・Pre-clinical development (e.g., lead-optimization, in-vivo studies, formulation development, chemistry and process validation)
  • ・Clinical development (e.g., Phase 1, Phase 2, Phase 3, manufacturing scale up)
  • ・Activities to support licensure and WHO prequalification

If you are interested in applying for the grant, please download RFP related documents.


RFP and Intent to Apply

Key RFP Milestone Dates

RFP Release

February 3, 2014

Intent to Apply

10:00 am March 17, 2014
Submit GHIT_RFP_IntentToApply.doc to RFPResponse@ghitfund.org
Email Subject Line: GHIT-RFP-2014-001 Intent to Apply

Q&A

Submit Questions to RFPResponse@ghitfund.org
no later than 10:00 am April 7, 2014
Email Subject Line: GHIT-RFP-2014-001 Questions

Full Proposal Due

10:00 am Tokyo Time April 15, 2014

Award Notification to All Applicants

No later than September 1, 2014

GHIT Fund RFP Product Development Platform 2013-002

The GHIT Fund announces a funding award opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration project may include R&D activities from pre-clinical research (post-lead optimization) through licensure. More specifically, we seek to fund a portfolio of innovative collaboration projects, such as:

  • ・Pre-clinical development (e.g., lead-optimization, in-vivo studies, formulation development, chemistry and process validation)
  • ・Clinical development (e.g., Phase 1, Phase 2, Phase 3, manufacturing scale up)
  • ・Activities to support licensure and WHO prequalification

If you are interested in applying for the grant, please download RFP related documents.


RFP and Intent to Apply

GHIT Fund RFP Product Development Platform 2013-001

The GHIT Fund announces a funding award opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration project may include R&D activities from pre-clinical research (post-lead optimization) through licensure. More specifically, we seek to fund a portfolio of innovative collaboration projects, such as:

  • ・Pre-clinical development (e.g., lead-optimization, in-vivo studies, formulation development, chemistry and process validation)
  • ・Clinical development (e.g., Phase 1, Phase 2, Phase 3, manufacturing scale up)
  • ・Activities to support licensure and WHO prequalification

If you are interested in applying for the grant, please download RFP related documents.


RFP and Intent to Apply